• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉扩张:当前概念与干预措施

Coronary artery ectasia: current concepts and interventions.

作者信息

Aboeata Ahmed S, Sontineni Siva P, Alla Venkata M, Esterbrooks Dennis J

机构信息

Creighton University School of Medicine, Division of Cardiology, 3006 Webster Street, Omaha, NE 68131, USA.

出版信息

Front Biosci (Elite Ed). 2012 Jan 1;4(1):300-10. doi: 10.2741/377.

DOI:10.2741/377
PMID:22201872
Abstract

Coronary artery ectasia (CAE) is a well-recognized angiographic finding, characterized by abnormal dilatation of the coronary arteries. We reviewed the current concepts of the condition including etiology, pathogenesis, flow alterations, clinical implications, prognosis and treatment. CAE is often viewed as a variant of obstructive coronary atherosclerosis. Exaggerated positive vascular remodeling due to inflammation, and chronic overstimulation of the endothelium by nitric oxide are potential causative mechanisms. The condition is associated with cardiovascular risk factors such as smoking and hypertension, while it appears to be inversely associated with age and diabetes mellitus. Patients with CAE typically present with angina, and are at risk for myocardial infarctions and sudden cardiac death due to slow flow, coronary vasospasm, dissection, and/or intracoronary thrombosis. CAE may be a diffuse disease associated with dilatation in other parts of the vasculature. As the incidence of this not so benign condition is expected to rise, the optimal treatment options remain undefined. Medical therapy with anticoagulants, nitrates and calcium channel blockers has been proposed and seems rational; however prospective studies with proof of efficacy are needed.

摘要

冠状动脉扩张(CAE)是一种公认的血管造影表现,其特征为冠状动脉异常扩张。我们回顾了关于该病症的当前概念,包括病因、发病机制、血流改变、临床意义、预后及治疗。CAE常被视为阻塞性冠状动脉粥样硬化的一种变体。炎症导致的过度正向血管重塑以及一氧化氮对内皮的慢性过度刺激是潜在的致病机制。该病症与吸烟和高血压等心血管危险因素相关,而似乎与年龄和糖尿病呈负相关。CAE患者通常表现为心绞痛,且因血流缓慢、冠状动脉痉挛、夹层分离和/或冠状动脉内血栓形成而有发生心肌梗死和心源性猝死的风险。CAE可能是一种与脉管系统其他部位扩张相关的弥漫性疾病。鉴于这种并非良性病症的发病率预计将会上升,最佳治疗方案仍不明确。已有人提出使用抗凝剂、硝酸盐和钙通道阻滞剂进行药物治疗,这似乎是合理的;然而需要有疗效证据的前瞻性研究。

相似文献

1
Coronary artery ectasia: current concepts and interventions.冠状动脉扩张:当前概念与干预措施
Front Biosci (Elite Ed). 2012 Jan 1;4(1):300-10. doi: 10.2741/377.
2
Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis?对一个古老争议的新见解:冠状动脉扩张是冠状动脉粥样硬化的一种变体吗?
Clin Res Cardiol. 2007 Jun;96(6):331-9. doi: 10.1007/s00392-007-0521-0. Epub 2007 Apr 26.
3
Coronary artery ectasia--is it time for a reappraisal?冠状动脉扩张——是时候重新评估了吗?
Clin Cardiol. 2007 May;30(5):214-7. doi: 10.1002/clc.20002.
4
Coronary artery ectasia in atherosclerotic coronary artery disease, inflammatory disorders, and sickle cell disease.动脉粥样硬化性冠状动脉疾病、炎症性疾病和镰状细胞病中的冠状动脉扩张。
Cardiovasc Ther. 2015 Apr;33(2):79-88. doi: 10.1111/1755-5922.12106.
5
Pharmacologic Management of Coronary Artery Ectasia.冠状动脉扩张症的药物治疗
Cureus. 2021 Sep 8;13(9):e17832. doi: 10.7759/cureus.17832. eCollection 2021 Sep.
6
Altered coronary flow properties in diffuse coronary artery ectasia.弥漫性冠状动脉扩张时冠状动脉血流特性的改变。
Am Heart J. 2003 Jan;145(1):66-72. doi: 10.1067/mhj.2003.48.
7
Heart rate variability and heart rate recovery in patients with coronary artery ectasia.冠状动脉扩张患者的心率变异性和心率恢复情况
Coron Artery Dis. 2010 Jan;21(1):8-12. doi: 10.1097/MCA.0b013e328332a69b.
8
Coronary artery ectasia as a culprit for acute myocardial infarction: review of pathophysiology and management.冠状动脉扩张作为急性心肌梗死的病因:病理生理学与管理综述
Anadolu Kardiyol Derg. 2013 Nov;13(7):695-701. doi: 10.5152/akd.2013.227. Epub 2013 Sep 26.
9
Coronary Artery Ectasia: Clinical and Angiographic Features.冠状动脉扩张:临床及血管造影特征
J Coll Physicians Surg Pak. 2018 Nov;28(11):824-828. doi: 10.29271/jcpsp.2018.11.824.
10
Clinical and angiographic characteristics of patients with coronary artery ectasia.冠状动脉扩张患者的临床和血管造影特征。
Int J Cardiol. 2013 Aug 20;167(4):1536-41. doi: 10.1016/j.ijcard.2012.04.098. Epub 2012 May 8.

引用本文的文献

1
A Pilot Study Investigating the Relationship Between Choroidal Thickness and Choroidal Vascular Index and Coronary Artery Ectasia.一项关于脉络膜厚度与脉络膜血管指数及冠状动脉扩张之间关系的初步研究。
Diagnostics (Basel). 2025 Jan 26;15(3):286. doi: 10.3390/diagnostics15030286.
2
Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management.急性冠状动脉综合征中的冠状动脉扩张:非维生素K拮抗剂口服抗凝药在治疗中的作用
Interv Cardiol. 2024 Nov 27;19:e25. doi: 10.15420/icr.2024.25. eCollection 2024.
3
Recurrent Acute Myocardial Infarction in a Patient with Severe Coronary Artery Ectasia Followed Up for 10 Years: Implications of Anticoagulant Therapy.
一名患有严重冠状动脉扩张的患者随访10年出现复发性急性心肌梗死:抗凝治疗的意义
Am J Case Rep. 2024 Dec 18;25:e945666. doi: 10.12659/AJCR.945666.
4
Risk factors and major adverse cardiovascular events of isolated coronary artery ectasia: An observational study.孤立性冠状动脉瘤的危险因素和主要不良心血管事件:一项观察性研究。
Medicine (Baltimore). 2024 Jun 7;103(23):e38413. doi: 10.1097/MD.0000000000038413.
5
The simultaneous occurrence of paraganglioma, Takotsubo syndrome, and Markis type I coronary artery ectasia in the same patient is a rare, high-risk clinical syndrome: a case report.同一患者同时发生副神经节瘤、Takotsubo 综合征和 Markis Ⅰ型冠状动脉扩张症是一种罕见的高危临床综合征:病例报告。
BMC Cardiovasc Disord. 2023 Nov 3;23(1):536. doi: 10.1186/s12872-023-03577-1.
6
Identification of Potential Abnormal Methylation-Modified Genes in Coronary Artery Ectasia.冠状动脉扩张中潜在异常甲基化修饰基因的鉴定
Int J Genomics. 2023 Aug 26;2023:4969605. doi: 10.1155/2023/4969605. eCollection 2023.
7
Outlook of coronary ectasia at the National Institute of Cardiology Ignacio Chávez: a cross-sectional study.国家心脏病学研究所冠状动脉扩张的展望:一项横断面研究。
Arch Cardiol Mex. 2023;93(2):197-202. doi: 10.24875/ACM.21000380.
8
Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.冠状动脉扩张中的炎症生物标志物:系统评价与荟萃分析
Diagnostics (Basel). 2022 Apr 19;12(5):1026. doi: 10.3390/diagnostics12051026.
9
Circulating microRNAs in patients with aneurysmal dilatation of coronary arteries.冠状动脉瘤样扩张患者的循环微小RNA
Exp Ther Med. 2022 Jun;23(6):404. doi: 10.3892/etm.2022.11331. Epub 2022 Apr 21.
10
Pharmacologic Management of Coronary Artery Ectasia.冠状动脉扩张症的药物治疗
Cureus. 2021 Sep 8;13(9):e17832. doi: 10.7759/cureus.17832. eCollection 2021 Sep.